98% Savings - Buy Urjas Massage Oil Just @9 Rs X
Gemfos is a prescription drug, available for use as Tablet. Post Menopausal Osteoporosis are some of its major therapeutic uses. Secondary and off-label uses of Gemfos have also been mentioned below.
The right dosage of Gemfos depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Gemfos include Musculoskeletal Pain (Bone, Muscle or Joint). Besides the aforementioned side effects, there are other adverse effects of Gemfos as well, which are listed below. Normally, these side effects of Gemfos are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Gemfos is Severe for pregnant women and Moderate for women who are breastfeeding. Warnings related to Gemfos's effects on the liver, heart and kidney, if any, have been listed below.
Gemfos can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Gemfos in conditions like Infections, Gastritis, Peptic Ulcer. Other contraindications of Gemfos have been discussed in the sections ahead.
Besides this, Gemfos may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Gemfos is safe while driving, and is addiction.
Gemfos is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemfos safe for pregnant women?
Gemfos shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Gemfos safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Gemfos. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Gemfos on the Kidneys?
Kidney can be affected by Gemfos. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Gemfos on the Liver?
Gemfos is rarely harmful for the liver.
What is the effect of Gemfos on the Heart?
Gemfos has very mild side effects on the heart.
Gemfos should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemfos unless your doctor advises you to do so -
Is this Gemfos habit forming or addictive?
Gemfos does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Gemfos as it does not make you drowsy.
Is it safe?
Yes, but consume Gemfos only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Gemfos for mental disorders.
Interaction between Food and Gemfos
Due to the absence of research, it is difficult to say how Gemfos and food will interact.
Interaction between Alcohol and Gemfos
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemfos with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actonel® (risedronate sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 1099-1102
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1099-1102